ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN
Concomitant correction of magnesium deficiency in children with uncontrolled asthma can improve the efficiency of basic therapy for achieving asthma control and possesses pharmacoeconomic benefits, reducing the cost of achieving control and cost per symptom-free day after 12 and 24 weeks of therapy....
Saved in:
| Main Authors: | V. I. Petrov, I. N. Shishimorov, O. V. Magnitskaya, Ju. V. Ponomareva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2015-03-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/56 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data
by: A. S. Kolbin, et al.
Published: (2016-11-01) -
MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY
by: D. V. Blinov, et al.
Published: (2015-03-01) -
MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT
by: E. I. Trisvetova
Published: (2015-09-01) -
Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma
by: S. V. Nedogoda, et al.
Published: (2024-02-01) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021-08-01)